A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste
bioRxiv (2022) - Comments
doi: 10.1101/2022.01.28.22270035 

Geoffrey Chupp, Anne Spichler-Moffarah, Ole S. Søgaard, Denise Esserman, James Dziura, Lisa Danzig, Reetika Chaurasia, Kailash P. Patra, Aryeh Salovey, Angela Nunez, Jeanine May, Lauren Astorino, Amisha Patel, Stephanie Halene, Jianhui Wang, Pei Hui, Prashant Patel., Jing Lu, Fangyong Li, Geliang Gan